Law360, New York (March 07, 2008, 12:00 AM ET) -- Eli Lilly & Co. was hit with a new lawsuit Thursday over its controversial anti-psychotic drug Zyprexa, this time filed by the state of Connecticut.
Echoing allegations that Eli Lilly already faces in a massive multidistrict litigation in the Eastern District of New York, Connecticut alleges that Eli Lilly first overcharged for the drug and then marketed it through a fraudulent campaign that concealed its possible link to diabetes.
The lawsuit also alleges that the company engaged in racketeering with medical marketing firms and doctors in...
Conn. Jumps Into Zyprexa Fray With Lawsuit
To view the full article, take a free trial now.
